Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 18, 2002
[Hepatic arterial infusion with irinotecan for the colorectal cancer patient with liver metastasis--a case report]Tatsuro Yamaguchi, Takeo Mori, Keiichi Takahashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 8, 2004
[A new systemic combination chemotherapy to be provided at home for patients with unresectable recurrent colorectal cancer]Keiichi Takahashi, Takeo Mori, Tatsuro Yamaguchi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 14, 2005
[The present and future of home care chemotherapy for patients with advanced and recurrent colorectal cancer]Keiichi Takahashi, Takeo Mori, Tatsuro Yamaguchi, et al.
Cancer Science|January 12, 2007
Overexpression of soluble vascular endothelial growth factor receptor 1 in colorectal cancer: Association with progression and prognosisTatsuro Yamaguchi, Hiroko Bando, Takeo Mori, et al.
Diseases of the Colon and Rectum|October 17, 2006
Indication and benefit of pelvic sidewall dissection for rectal cancerKenichi Sugihara, Hirotoshi Kobayashi, Tomoyuki Kato, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 2, 2003
[Controversy about treatment of colorectal cancer in view of surgeon--lymph node dissection for colorectal surgery (lateral lymph node dissection and TME)]Tatsuro Yamaguchi, Takeo Mori, Keiichi Takahashi, et al.
Diseases of the Colon and Rectum|October 8, 2003
Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutionsTomoyuki Kato, Kenzo Yasui, Takashi Hirai, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|August 18, 2004
[A new systemic combination chemotherapy to be provided at home for patients with unresectable recurrent colorectal cancer]Keiichi Takahashi, Takeo Mori, Tatsuro Yamaguchi, et al.
Oncology Reports|December 13, 2012
Factors predicting the response to oral fluoropyrimidine drugs: a phase II trial on the individualization of postoperative adjuvant chemotherapy using oral fluorinated pyrimidines in stage III colorectal cancer treated by curative resection (ACT-01 Study)Takeo Mori, Masayuki Ohue, Yasumasa Takii, et al.
Diseases of the Colon and Rectum|January 20, 2006
Accumulation profile of frameshift mutations during development and progression of colorectal cancer from patients with hereditary nonpolyposis colorectal cancerTatsuro Yamaguchi, Takeru Iijima, Takeo Mori, et al.
Pageof 5